02:46 PM EST, 12/03/2024 (MT Newswires) -- Andrew D Dickinson, Chief Financial Officer, on November 29, 2024, sold 248,645 shares in Gilead Sciences ( GILD ) for $23,065,271. Following the Form 4 filing with the SEC, Dickinson has control over a total of 138,919 shares of the company, with 138,919 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/882095/000112760224028397/xslF345X05/form4.xml

Price: 93.70, Change: -0.32, Percent Change: -0.34